Back to companies

Kiniksa Pharmaceuticals International Plc: Deals

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

View up-to-date information on Kiniksa Pharmaceuticals International Plc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.

Number of Deals

image for loader

Deal Value ($M)

Image for Loader
Gain insight into company strategy with premium access to M&A activity Gain insight into company strategy with premium access to M&A activity Register your interest

Latest Deals

Announced Date Headline Deal Type Acquirers/Investors/Surviving Entity Issuer/Partner/Target
02 Aug 2022 Genentech and Roche Enters into Licensing Agreement with Kiniksa Pharma UK Licensing Agreement Genentech USA Inc
F. Hoffmann-La Roche Ltd
Kiniksa Pharmaceuticals UK Ltd  

06 May 2022 Kiniksa Pharma to Raise Funds through Public Offering of Shares Equity Offering - Kiniksa Pharmaceuticals Ltd
22 Feb 2022 Hangzhou Zhongmei Huadong Pharma Enters into Collaboration with Kiniksa Pharma Partnership -
Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd  

Kiniksa Pharmaceuticals Ltd
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
Explore the latest deals, partnerships, mergers & acquisitions when you unlock full profile Explore the latest deals, partnerships, mergers & acquisitions when you unlock full profile Register your interest
Get in touch about GlobalData Explorer

Contact the team or request a demo to find out how our data can drive your business forward

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer